Financial Performance - The company reported revenue of HKD 28,176,000 for the six months ending June 30, 2025, representing a 8.7% increase from HKD 25,921,000 in the same period of 2024[4] - Gross profit for the same period was HKD 19,280,000, up 37.5% from HKD 14,034,000 year-over-year[4] - The net loss for the six months was HKD 2,385,000, compared to a net loss of HKD 1,609,000 in the previous year, indicating a deterioration in performance[4] - The company reported a basic and diluted loss per share of HKD 0.53 for the period, compared to HKD 0.23 in the previous year[4] - The group reported revenue of HKD 28,176,000 for the six months ended June 30, 2025, compared to HKD 25,921,000 for the same period in 2024, representing an increase of approximately 8.7%[18] - The total operating profit for the group was HKD 6,481,000 for the six months ended June 30, 2025, compared to HKD 1,422,000 in the previous year, reflecting a substantial improvement[19] - The group incurred a net loss before tax of HKD 2,575,000 for the six months ended June 30, 2025, compared to a loss of HKD 1,681,000 in the same period of 2024, indicating a worsening financial position[19] Assets and Liabilities - Total assets decreased to HKD 107,363,000 as of June 30, 2025, down from HKD 113,445,000 at the end of 2024[7] - The company's cash and bank balances stood at HKD 62,616,000, slightly down from HKD 63,463,000 at the end of 2024[7] - Total liabilities decreased to HKD 63,143,000 from HKD 67,766,000, indicating improved financial leverage[8] - The company’s equity attributable to shareholders decreased to HKD 37,019,000 from HKD 39,638,000 year-over-year[7] - The group’s total liabilities as of June 30, 2025, were approximately HKD 40,545,000, a decrease from HKD 45,011,000 as of December 31, 2024[35] - As of June 30, 2025, total assets were approximately HKD 107,363,000, with total liabilities of about HKD 22,737,000, resulting in a debt-to-asset ratio of approximately 21.18%[55] - The debt-to-equity ratio was approximately 61% as of June 30, 2025, down from 63% at the end of the previous year[56] Segment Performance - The healthcare and medical segment generated revenue of HKD 6,954,000 for the six months ended June 30, 2025, up from HKD 1,882,000 in the previous year, indicating significant growth[19] - The beauty and fitness segment reported a loss of HKD 473,000 for the six months ended June 30, 2025, compared to a loss of HKD 460,000 in the same period of 2024, showing a slight increase in losses[19] Expenses and Costs - Direct costs and operating expenses were approximately HKD 8,896,000, a decrease of about 25.16% from HKD 11,887,000 in 2024, primarily due to reduced goods costs[44] - Sales expenses were approximately HKD 6,803,000, an increase of about 1.81% from HKD 6,682,000 in 2024[46] - Administrative expenses for the period were approximately HKD 10,083,000, a decrease of about 14.28% compared to the same period last year[47] - The company’s employee benefit expenses were HKD 11,451,000 for the six months ended June 30, 2025, slightly down from HKD 12,488,000 in the same period of 2024, a decrease of 8.3%[24] Impairment and Losses - The company incurred impairment losses of HKD 3,408,000 related to trademark rights and professional skills, which were not present in the previous year[4] - The impairment loss for the cash-generating unit in the beauty and fitness business was approximately HKD 3,408,000, with a total of HKD 2,149,000 attributed to property, plant, and equipment[48] Governance and Compliance - The company confirms compliance with the corporate governance code, with recent appointments ensuring adherence to the required standards[70] - The audit committee consists of three independent non-executive directors, including Ms. Marsha (Chair), Mr. Wu Hong, and Mr. Wang Chunlin, with Ms. Marsha holding recognized accounting qualifications[73] - The unaudited condensed consolidated financial statements for the period have been reviewed by the audit committee, which believes that the statements comply with applicable accounting standards and listing rules[73] Future Plans and Strategy - The group aims for stable revenue growth while reducing unnecessary expenses and improving profitability without committing to any major acquisitions or expansion plans at this time[42] - The group plans to utilize the remaining HKD 42.4 million from the 2020 rights issue for management expenses if suitable acquisition targets are not identified[54] Miscellaneous - The company did not declare any dividends for the six months ended June 30, 2025, consistent with the previous year[29] - The group employs 162 employees in Hong Kong and China as of June 30, 2025[67] - There are no significant ongoing or threatened litigations against the company or its subsidiaries[68] - The company has engaged an external consultant for internal audit functions due to the absence of an internal audit capability[71] - The group did not engage in any capital raising activities during the period[51] - There were no acquisitions or disposals of subsidiaries during the period[58]

董事會會議日期 格林國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈， 本公司董事會謹訂於2025年8月29日假座香港干諾道中200號信德中心西座 17樓1708室舉行董事會會議，籍以（ 其中包括 ）考慮及批准本公司及其附屬 公司截至2025年6月30日止六個月之中期業績及考慮派付中期股息（ 如有 ）的 建議。 香 港 交易 及 結 算 所 有限 公 司 及 香港 聯 合 交 易 所有 限 公 司 對 本公 告 之 內 容概 不 負 責， 對 其 準 確 性或 完 整 性 亦不 發 表 任 何 聲明 ， 並 明 確 表示 概 不 就 因本 公 告 全部 或 任 何 部 分內 容 而 產 生或 因 倚 賴 該 等內 容 而 引 致 之任 何 損 失 承擔 任何責任。 GREEN INTERNATIONAL HOLDINGS LIMITED 格 林 國 際 控 股 有 限 公 司 （ 於開曼群島註冊成立之有限公司 ） （股份代號：2700） 承董事會命 格林國際控股有限公司 主席 俞周杰 香港，2025年8月20日 於本公告日期，執行董事為俞周杰先生（ 主席 ）及余向進先生；非執行董事 為 ...

截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 格林國際控股有限公司 呈交日期: 2025年8月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定/註冊股本 ...

Core Points - GAMECO has officially obtained ISO27001 certification, becoming one of the few aircraft maintenance companies in the industry to achieve this international standard, marking a significant step towards its goal of becoming a world-class aviation maintenance enterprise [1][2] - ISO27001 is an international standard aimed at helping organizations establish, implement, maintain, and continuously improve their information security management systems, focusing on risk management principles to protect the confidentiality, integrity, and availability of information [1] - Under the requirements of its shareholder, China Southern Airlines, GAMECO has been mandated to enhance its data processing compliance management system, including information security aspects, with some international clients requiring ISO27001 certification as a prerequisite for service providers [1] Company Initiatives - GAMECO formed a project team to advance the certification process, achieving efficient implementation through collaboration across departments, identifying over 17,000 information assets, assessing and addressing 2,500 risks, conducting more than 10 training sessions, and developing 45 system manuals and procedures [1] - The successful certification enhances GAMECO's credibility and competitiveness within the industry, allowing for accelerated application of information technology in the aviation maintenance sector, thereby injecting new momentum for high-quality development [2]

Company Overview - Green International Holdings Limited is an investment holding company primarily engaged in providing healthcare and medical services, beauty and fitness services, and comprehensive financial services including lending, securities brokerage, and asset management [2]. Financial Performance - As of December 31, 2024, Green International Holdings reported total revenue of 49.0894 million, representing a year-on-year growth of 8.56% [1]. - The company recorded a net profit attributable to shareholders of -0.7473 million, showing a significant year-on-year improvement of 92.41% [1]. - The gross profit margin stood at 59.8%, while the debt-to-asset ratio was 59.73% [1]. Stock Performance - As of May 27, the stock price of Green International Holdings closed at 0.6 HKD per share, marking an increase of 31.87% with a trading volume of 120,200 shares and a turnover of 68,100 HKD [1]. - Over the past month, the stock has experienced a cumulative decline of 20.18%, while year-to-date, it has increased by 12.35%, underperforming the Hang Seng Index by 16.06% [1]. Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -19.72 times, with a median of 0.3 times [1]. - Green International Holdings has a P/E ratio of -372.06 times, ranking 53rd in the industry [1]. - Comparatively, other companies in the sector have the following P/E ratios: Giant Medical Holdings at 0.23 times, Jingjiu Health at 0.38 times, Yongsheng Medical at 3.97 times, Global Medical at 4.58 times, and China Regenerative Medicine at 5.14 times [1].

Financial Performance - Total revenue increased from HKD 48.83 million in 2023 to HKD 53.01 million in 2024, representing an increase of approximately 8.56%[16] - Net profit rebounded from a loss of HKD 8.79 million in 2023 to a profit of HKD 2.87 million in 2024[7] - Gross profit for the year was approximately HKD 31.70 million, up about 9.96% from HKD 28.83 million in 2023, with a gross margin of 59.80%[18] - Direct costs and operating expenses rose to approximately HKD 21.31 million, an increase of about 6.54% compared to HKD 20.00 million in 2023[17] - Sales expenses decreased by approximately 14.07% to about HKD 11.40 million from HKD 13.27 million in 2023 due to cost control measures[19] - Administrative expenses increased to approximately HKD 23.47 million, up about 6.74% from HKD 21.99 million in 2023, primarily due to increased depreciation costs after the relocation of Yiyang Hospital[20] - The group's financing costs for the year were approximately HKD 1,688,000, a decrease from HKD 2,278,000 in 2023[24] - The net profit for the year was approximately HKD 2,871,000, compared to a loss of HKD 8,791,000 in 2023[25] Business Segments - The healthcare and medical business segment benefited from favorable government policies, particularly in Hunan Province, which improved reimbursement rates for dialysis services[7] - The company closed two unprofitable beauty salons and scaled down another to reduce expenses in the beauty and fitness segment[13] - The beauty and fitness business cash-generating unit reported impairment losses of approximately HKD 2,442,000 for trademarks and professional skills, HKD 209,000 for properties, and HKD 1,692,000 for equipment and right-of-use assets in the current year[23] Assets and Liabilities - As of December 31, 2024, the group had total assets of approximately HKD 113,445,000 and total liabilities of approximately HKD 25,108,000, resulting in a leverage ratio of approximately 22.13%[30] - The current ratio as of December 31, 2024, was approximately 1.30, compared to 1.24 as of December 31, 2023[30] - The group had cash and bank balances of approximately HKD 63,463,000 as of December 31, 2024, down from HKD 66,826,000 in 2023[31] - The debt-to-equity ratio as of December 31, 2024, was approximately 63%, a significant improvement from 123% in 2023[32] - The group did not engage in any significant acquisitions or disposals of subsidiaries, associates, or joint ventures during the year[34] - The group has no significant contingent liabilities as of December 31, 2024[36] Shareholder Information - The company does not recommend any dividend payment for the current year, maintaining a dividend of zero for 2023[46] - The total reserves available for distribution to equity shareholders as of December 31, 2024, is zero HKD, unchanged from 2023[63] - The company did not recommend a final dividend for the year ending December 31, 2024, consistent with the previous year where no dividend was paid[60] - As of December 31, 2024, the total issued shares amount to 659,894,693[75] - Liu Dong holds 25,146,000 shares, representing approximately 3.81% of the total issued shares[75] - Zhou Cuiqiong holds 370,071,730 shares, representing approximately 56.08% of the total issued shares[75] - Wei Xin International Limited, controlled by Zhou Cuiqiong, holds 370,071,730 shares, also representing approximately 56.08% of the total issued shares[76] - Chang Jian Limited, a subsidiary of Wei Xin, holds 67,647,058 shares, representing approximately 10.25% of the total issued shares[76] - The company did not engage in any share buybacks, sales, or redemptions during the year[66] - There were no related party transactions reported during the year[67] Corporate Governance - The board of directors presented the annual report and audited consolidated financial statements for the year ending December 31, 2024[56] - The board includes two executive directors, three non-executive directors, and three independent non-executive directors, providing a balanced distribution of expertise[110] - The company has established procedures for directors to seek independent advice to fulfill their responsibilities, with costs covered by the company[109] - The company has confirmed that all directors have adhered to the standards of conduct for trading securities as outlined in the listing rules[120] - The company has arranged appropriate liability insurance for its directors and senior management, with coverage reviewed annually[126] - The board has established three committees: the audit committee, the remuneration committee, and the nomination committee, to oversee various aspects of the group[130] - The audit committee consists of three independent non-executive directors, ensuring compliance with applicable accounting standards and listing rules[102] - The audit committee's main functions include reviewing financial statements and reports, and ensuring the effectiveness of the company's financial reporting and risk management systems[132] - The remuneration committee consists of four members, including the chairman and three independent non-executive directors, responsible for reviewing and approving executive compensation policies[137] - The nomination committee evaluates the performance of executive directors and reviews the remuneration policies for directors and senior management[139] Risk Management and Internal Controls - The company has engaged an external consultant to maintain and execute internal audit functions due to the absence of an internal audit department[107] - The board monitors risk management and internal control systems, regularly reviewing their effectiveness[109] - The company conducts an annual risk assessment to identify potential strategic, operational, financial, and compliance risks, categorizing them as high, medium, or low based on their likelihood and impact on business objectives[146] - The internal control review plan prioritizes identified risks for annual internal monitoring, with the board confirming the effectiveness and adequacy of the risk management and internal control systems for the year[147] - The company has established an internal audit function to enhance its risk management and internal control systems[145] Environmental, Social, and Governance (ESG) - The company emphasizes environmental protection and is committed to sustainable practices, including promoting the use of eco-friendly paper and reducing energy consumption[100] - The company is committed to sustainable development principles and aims to balance economic growth, environmental protection, and social responsibility[173] - The company has established a governance framework to integrate environmental, social, and governance factors into its decision-making processes[174] - The board of directors is responsible for overseeing the company's environmental, social, and governance strategies and reporting[175] - The company has adopted a shareholder communication policy to ensure timely and equal access to information for shareholders and potential investors[161] - The company conducted an annual materiality assessment in 2024 to ensure the relevance of its ESG strategies[180] - The company aims to reduce greenhouse gas emissions by 5% by 2026, using 2021 as the baseline[188] - The company has implemented measures to manage energy consumption, including maintaining air conditioning at 25 degrees Celsius and promoting carpooling[197] - The company adheres to all relevant environmental laws and regulations in China, ensuring compliance with the latest environmental standards[185] - The company promotes a paperless office environment to reduce waste and improve energy efficiency[200] - The company has established a waste management strategy that includes recycling and proper disposal of electronic waste[191] - The company actively engages with stakeholders to identify significant environmental, social, and governance issues[182] - The company has a comprehensive environmental management policy to achieve its environmental goals[185]

Financial Performance - Total revenue for the year ended December 31, 2024, was HKD 53,010,000, an increase of 8.9% compared to HKD 48,831,000 in 2023[4] - Gross profit for the same period was HKD 31,698,000, up from HKD 28,828,000, reflecting a gross margin improvement[4] - The net profit for the year was HKD 2,871,000, a significant recovery from a net loss of HKD 8,791,000 in 2023[4] - The company reported a basic and diluted loss per share of HKD 0.12, improved from HKD 1.61 in the previous year[4] - Total operating profit for the company reached HKD 11,191,000 in 2024, a turnaround from a loss of HKD 613,000 in 2023[22] - The group reported a net profit of approximately HKD 2,871,000 for the year, compared to a loss of HKD 8,791,000 in 2023[56] Revenue Breakdown - The group's revenue for the year ending December 31, 2024, reached HKD 53,010,000, with healthcare and medical services contributing HKD 39,705,000 and beauty and fitness services contributing HKD 13,305,000[19] - For the year ending December 31, 2023, the group's revenue was HKD 48,831,000, with healthcare and medical services at HKD 31,212,000 and beauty and fitness services at HKD 17,619,000, indicating a year-over-year growth in total revenue of approximately 8.9%[19] - Total revenue for the healthcare and medical business was HKD 39,705,000 in 2024, up from HKD 31,212,000 in 2023, reflecting a growth of 27.9%[29] - Total revenue for the beauty and fitness business decreased to HKD 13,305,000 in 2024 from HKD 17,619,000 in 2023, a decline of 24.5%[29] Assets and Liabilities - Total assets decreased to HKD 113,445,000 from HKD 136,201,000, indicating a reduction in overall asset base[6] - Total liabilities were reduced to HKD 67,766,000 from HKD 92,589,000, showing a decrease in financial obligations[7] - As of December 31, 2024, the group has total assets of approximately HKD 113,445,000 and total liabilities of approximately HKD 25,108,000, resulting in a leverage ratio of about 22.13%[62] - The current ratio as of December 31, 2024, is approximately 1.30, compared to 1.24 as of December 31, 2023[62] Operational Highlights - The company plans to focus on market expansion and new product development in the upcoming fiscal year[3] - The management highlighted ongoing efforts in technology research and development to enhance competitive positioning[3] - The healthcare and medical segment operates blood dialysis centers and hospitals, while the beauty and fitness segment focuses on the sale of beauty and fitness products and related services[20] - The healthcare and medical services segment continues to operate hospitals in Hunan Province, China, optimizing supply chain procurement and increasing the use of domestic medical supplies[45] Expenses and Costs - Direct costs and operating expenses amounted to approximately HKD 21,312,000, reflecting an increase of about 6.54% from HKD 20,003,000 in 2023[49] - Selling expenses decreased to approximately HKD 11,403,000, down about 14.07% from HKD 13,270,000 in 2023 due to cost control measures[51] - Administrative expenses increased to approximately HKD 23,471,000, up about 6.74% from HKD 21,989,000 in 2023, primarily due to increased depreciation costs after the relocation of a hospital[52] - Employee benefit expenses increased to HKD 24,365,000 in 2024 from HKD 22,728,000 in 2023, marking an increase of about 7.2%[32] - Financing costs decreased to HKD 1,688,000 in 2024 from HKD 2,278,000 in 2023, a reduction of 26%[31] Corporate Governance and Compliance - The financial statements are prepared in accordance with the Hong Kong Financial Reporting Standards, ensuring compliance with local accounting regulations[11] - The group has adopted several revised Hong Kong Financial Reporting Standards effective from January 1, 2024, which do not have a significant impact on the current and prior financial positions[13] - The company confirmed compliance with the Corporate Governance Code, except for the absence of an internal audit function due to operational scale[81] - An external consultant has been hired to establish an internal audit function and assist in reviewing the adequacy and effectiveness of the risk management and internal control systems[82] - The audit committee consists of three independent non-executive directors, with Mr. Cai Davi serving as the chairman, ensuring compliance with applicable accounting standards[85] Shareholder Information - The company did not declare any dividends for the year ending December 31, 2024, consistent with the previous year[37] - The company has maintained a weighted average number of ordinary shares issued at 659,894,693 for both 2024 and 2023, indicating stability in share capital[43] - The board does not recommend the payment of any dividends for the year[76] Employee and Operational Changes - The group employed 180 employees in Hong Kong and China as of December 31, 2024[77] - The group closed two loss-making beauty salons and reduced the scale of one salon in 2024 to cut costs[46] - The company did not buy, sell, or redeem any of its listed securities during the year[80] Miscellaneous - There are no significant ongoing or threatened litigations against the group as of the announcement date[78] - The company expresses gratitude to its directors, employees, shareholders, customers, suppliers, banks, and business partners for their support[88]

Company Overview - Green International Holdings Limited is an investment holding company primarily engaged in providing (i) healthcare and medical services, (ii) beauty and fitness services, and (iii) comprehensive financial services including lending, securities brokerage, and asset management [3] Stock Performance - As of March 31, the Hang Seng Index fell by 1.31%, closing at 23,119.58 points. Green International Holdings closed at HKD 0.5 per share, up by 11.11%, with a trading volume of 70,000 shares and a turnover of HKD 36,000, showing a volatility of 6.67% [1] - Over the past month, Green International Holdings has seen a cumulative increase of 12.5%, while year-to-date, it has risen by 11.11%, underperforming the Hang Seng Index which has increased by 16.78% [2] Financial Performance - For the fiscal year ending June 30, 2024, Green International Holdings reported total revenue of HKD 23.6576 million, reflecting a year-on-year growth of 3.23%. However, the net profit attributable to shareholders was a loss of HKD 1.3891 million, which is an improvement of 66.67% compared to the previous year. The gross margin stood at 54.14%, and the debt-to-asset ratio was 68.85% [2] Valuation Metrics - Currently, there are no institutional investment ratings for Green International Holdings. The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -18.88 times, with a median of 2.45 times. Green International Holdings has a P/E ratio of -39.17 times, ranking 63rd in the industry [3]

Financial Performance - Revenue for the six months ended June 30, 2024, was HKD 25,921 thousand, a 3.2% increase from HKD 25,109 thousand in the same period of 2023[24] - Gross profit for the same period was HKD 14,034 thousand, up 14.9% from HKD 12,210 thousand year-on-year[24] - Loss before tax decreased to HKD 1,681 thousand, compared to a loss of HKD 4,789 thousand in the previous year, representing a 64.9% improvement[24] - Total comprehensive loss for the period was HKD 1,999 thousand, significantly reduced from HKD 5,077 thousand in the prior year, marking a 60.7% decrease[25] - The company reported a basic and diluted loss per share of HKD 0.23, an improvement from HKD 0.69 in the same period last year[24] - The group reported a net loss of HKD 1,609 million for the six months ended June 30, 2024, compared to a net loss of HKD 4,704 million for the same period in 2023, reflecting a reduction of 65.8%[46] - The group's net loss for the period was approximately HKD 1,609,000, a reduction of about 65.80% compared to HKD 4,704,000 in the previous year, primarily due to lower administrative expenses[77] Assets and Liabilities - Total assets as of June 30, 2024, were HKD 133,585 thousand, down from HKD 136,201 thousand at the end of 2023[26] - Current liabilities increased to HKD 66,153 thousand from HKD 64,551 thousand, reflecting a 2.5% rise[27] - Non-current assets decreased to HKD 54,416 thousand from HKD 56,183 thousand, a decline of 3.1%[26] - The company’s equity attributable to owners decreased from HKD (986,479) thousand at the beginning of the period to HKD (991,045) thousand by June 30, 2024[28] - As of June 30, 2024, the group had total assets of approximately HKD 133,585,000 and liabilities of about HKD 49,840,000, resulting in a debt-to-asset ratio of approximately 37.31%[82] - The current ratio as of June 30, 2024, was approximately 1.20, with current assets of about HKD 79,169,000 exceeding current liabilities of HKD 66,153,000[82] Cash Flow - For the six months ended June 30, 2024, the net cash generated from operating activities was HKD 3,089 thousand, compared to a net cash used of HKD 4,415 thousand in the same period of 2023[29] - The total cash and cash equivalents as of June 30, 2024, amounted to HKD 65,356 thousand, a decrease from HKD 72,265 thousand as of June 30, 2023[29] - Cash and cash equivalents decreased to HKD 65,356 thousand from HKD 66,826 thousand, a decline of 2.2%[26] - The cash flow from investing activities for the six months ended June 30, 2024, was HKD 1,223 thousand, compared to HKD 540 thousand in the same period of 2023[29] Segment Performance - The healthcare and medical segment generated revenue of HKD 1,882 million for the six months ended June 30, 2024, compared to HKD 1,187 million in the same period of 2023, representing a growth of 58.7%[46] - The beauty and fitness segment reported revenue of HKD 460 million for the six months ended June 30, 2024, down from HKD 1,704 million in the same period of 2023, indicating a decline of 73.0%[46] - The beauty and fitness business performance remained sluggish due to a sharp decline in the service industry and weak consumer market in China[69] Operational Changes and Strategies - The company aims to enhance market expansion and product development strategies in the upcoming quarters[19] - The group plans to close one beauty and fitness business location in the second half of 2024 to optimize cost efficiency and ensure strategic placement of its stores[70] - The company has faced challenges from market competitors in its healthcare and medical business segment[67] - The company has no immediate plans for significant acquisitions or expansions due to the cautious approach adopted in response to healthcare system reforms[79] Financial Risks and Compliance - The company continues to face various financial risks, including foreign exchange risk, credit risk, liquidity risk, and cash flow and fair value interest rate risk[37] - The company has adopted revised Hong Kong Financial Reporting Standards effective from January 1, 2024, which did not result in significant changes to the financial statements[34] - The board confirms compliance with the standards for securities trading as per the listing rules for the six months ending June 30, 2024[103] Shareholder Information - The board did not recommend any dividend payment for the six months ended June 30, 2024, consistent with the previous year[55] - The company expresses gratitude to shareholders, customers, suppliers, and banks for their continued support during the reporting period[106] Audit and Governance - The company has engaged an external consultant for internal audit functions, ensuring the adequacy and effectiveness of the risk management and internal control systems[102] - The audit committee consists of three independent non-executive directors, with one member holding recognized accounting qualifications and extensive experience in auditing and accounting[104] Employment and Legal Matters - The company employed 181 staff in Hong Kong and China as of June 30, 2024[93] - There were no significant ongoing or threatened litigations against the company or its subsidiaries[94]

Financial Performance - For the six months ended June 30, 2024, the company reported revenue of HKD 25,921,000, an increase of 3.2% compared to HKD 25,109,000 for the same period in 2023[2] - Gross profit for the same period was HKD 14,034,000, representing a gross margin of 54.2%, up from HKD 12,210,000 in 2023[2] - The net loss for the six months ended June 30, 2024, was HKD 1,609,000, a significant improvement from a net loss of HKD 4,704,000 in the prior year[3] - Basic and diluted loss per share for the period was HKD 0.23, compared to HKD 0.69 for the same period in 2023[2] - The net loss for the period was approximately HKD 1,609,000, a reduction of about 65.80% compared to HKD 4,704,000 in the previous year[36] Assets and Liabilities - Total assets as of June 30, 2024, were HKD 133,585,000, a decrease from HKD 136,201,000 as of December 31, 2023[4] - The company's cash and cash equivalents stood at HKD 65,356,000, down from HKD 66,826,000 at the end of 2023[4] - Non-current liabilities decreased to HKD 25,815,000 from HKD 28,038,000 in the previous period[5] - Current liabilities increased slightly to HKD 66,153,000 from HKD 64,551,000 as of December 31, 2023[5] - The company reported a total equity of HKD 41,617,000, down from HKD 43,612,000 at the end of 2023[4] - The group's liabilities as of June 30, 2024, are approximately HKD 49.840 million, down from HKD 50.759 million as of December 31, 2023, resulting in a leverage ratio of approximately 37.31%[40] - The net current assets as of June 30, 2024, are approximately HKD 13.016 million, compared to HKD 15.467 million as of December 31, 2023[41] - The current ratio as of June 30, 2024, is approximately 1.20, down from 1.24 as of December 31, 2023[41] - The debt-to-equity ratio as of June 30, 2024, is approximately 127%, an increase from 123% as of December 31, 2023[42] Revenue Breakdown - The healthcare and medical business generated revenue of HKD 18,377,000 for the six months ended June 30, 2024, up from HKD 15,814,000 in the same period of 2023, reflecting a growth of 16.2%[10] - The beauty and wellness business reported revenue of HKD 7,544,000 for the six months ended June 30, 2024, down from HKD 9,295,000 in the same period of 2023, indicating a decline of 18.8%[10] - The healthcare and medical business segment's revenue increased by approximately 16.21% from HKD 15.81 million to HKD 18.38 million[27] - The group's total revenue for the period was approximately HKD 25,921,000, representing a slight increase of about 3.23% compared to HKD 25,109,000 in the previous year[30] Expenses - Direct costs and operating expenses decreased by approximately 7.85% to HKD 11,887,000 from HKD 12,899,000 in the previous year[31] - Selling expenses decreased by approximately 9.26% to HKD 6,682,000 from HKD 7,364,000 in the previous year[33] - Administrative expenses decreased by approximately 25.59% to HKD 11,763,000 from HKD 15,808,000 in the previous year[34] - Employee benefits expenses for the six months ended June 30, 2024, amounted to HKD 12,488,000, compared to HKD 11,861,000 for the same period in 2023, representing an increase of 5.3%[14] - Financing costs decreased by approximately 8.72% to HKD 1,026,000 from HKD 1,124,000 in the previous year[35] Corporate Governance - The company has confirmed compliance with the corporate governance code, except for the absence of an internal audit function due to operational scale[52] - The audit committee consists of three independent non-executive directors, with one member holding professional accounting qualifications[54] - The interim financial statements have been reviewed by the audit committee and are deemed to comply with applicable accounting standards and listing rules[54] - The company has adopted the standard code for securities trading by directors and confirmed adherence to it for the six months ending June 30, 2024[53] Future Outlook and Investments - The company continues to focus on providing healthcare and wellness services, with ongoing investments in new products and technologies[6] - The total capital expenditure budget for the relocation of Yiyang Hospital was approximately RMB 17.3 million (HKD 19.5 million)[38] - As of June 30, 2024, approximately RMB 16.4 million (HKD 18.5 million) has been utilized for the relocation of Yiyang Hospital, with the remaining budget expected to be fully utilized by Q1 2025[38] Dividend and Share Capital - The company does not recommend any dividend payment for the six months ended June 30, 2024, consistent with the previous period[18] - The company’s total issued and paid-up share capital remained unchanged at 659,894,693 shares as of June 30, 2024, consistent with the previous period[25] Compliance and Reporting - The interim results announcement has been published on the Hong Kong Stock Exchange and the company's website, with the full interim report to be sent to shareholders by September 30, 2024[55] - The company has not reported any revenue from a single customer exceeding 10% of total revenue for the periods ended June 30, 2024, and 2023[10]